Other OTC Pharmaceuticals - Southern Europe

  • Southern Europe
  • In Southern Europe, the revenue generated in the market Other OTC Pharmaceuticals amounted to US$3.33bn in 2024.
  • It is projected that the market will experience an annual growth rate of 0.94% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, reaching US$7,171.00m in 2024.
  • In terms of per capita figures, each person in Southern Europe generates revenues of US$14.05 in 2024.
  • In Southern Europe, Italy has seen a surge in demand for natural and herbal OTC pharmaceuticals in the Other OTC Pharmaceuticals market.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Southern Europe is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Southern Europe are driving the demand for Other OTC Pharmaceuticals. Consumers in this region are increasingly seeking self-medication options for minor ailments and health issues. They prefer the convenience and accessibility of over-the-counter products that can be purchased without a prescription. Additionally, customers are becoming more health-conscious and are actively seeking preventive measures to maintain their well-being. This has led to an increased demand for OTC pharmaceuticals that offer preventive benefits, such as vitamins and dietary supplements.Trends in the market further contribute to the growth of the Other OTC Pharmaceuticals sector in Southern Europe. The region is witnessing a rise in e-commerce platforms and online pharmacies, which provide a wide range of OTC products at competitive prices. This trend has made it easier for consumers to access and purchase OTC pharmaceuticals from the comfort of their homes. Furthermore, there is a growing awareness and acceptance of alternative medicine and natural remedies in Southern Europe. This has led to an increased demand for herbal and homeopathic OTC products, as consumers seek more holistic and natural solutions for their health needs.Local special circumstances also play a role in the development of the Other OTC Pharmaceuticals market in Southern Europe. The region has a well-established healthcare system that emphasizes self-care and encourages individuals to take responsibility for their own health. This cultural mindset aligns with the concept of OTC pharmaceuticals, where individuals can take control of their health by choosing and using the appropriate products. Additionally, Southern Europe has a large aging population, which drives the demand for OTC products that cater to age-related health issues, such as joint pain and digestive problems.Underlying macroeconomic factors contribute to the growth of the Other OTC Pharmaceuticals market in Southern Europe. The region has experienced economic stability and a growing middle class, which has increased disposable incomes and purchasing power. As a result, consumers are more willing to spend on OTC pharmaceuticals to address their healthcare needs. Furthermore, the region's healthcare infrastructure and regulatory environment support the growth of the OTC market, providing a favorable landscape for manufacturers and retailers to operate.In conclusion, the Other OTC Pharmaceuticals market in Southern Europe is developing due to customer preferences for self-medication, trends in the market such as e-commerce and alternative medicine, local special circumstances like a focus on self-care and an aging population, and underlying macroeconomic factors including economic stability and a growing middle class. This growth is expected to continue as consumers in Southern Europe seek convenient and accessible healthcare solutions for their minor ailments and preventive needs.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)